About
Coastline Bio is a biopharmaceutical company focused on developing novel treatments for immunological skin diseases, primarily atopic dermatitis, using a first-in-class monoclonal antibody in preclinical development.
Explore Coastlinebio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.